ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

21,242Medicare Part D Prescriptions Filled, Including Refills

Rank: 23 out of 890

$1M Total Retail Price of All Prescriptions

Rank: 50 out of 890

832 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
45% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

9% of this provider’s 832 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

1% of this provider’s 16,618 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
LEVOTHYROXINE SODIUM 967 820 1 2
SIMVASTATIN 769 603 2 5
AMLODIPINE BESYLATE 754 631 3 1
LISINOPRIL 753 643 4 4
OMEPRAZOLE 608 465 5 8
PRAVASTATIN SODIUM 588 445 6 10
METFORMIN HCL 542 490 7 6
ATORVASTATIN CALCIUM 511 412 8 13
CITALOPRAM HBR 459 382 9 20
FUROSEMIDE 365 228 10 7
HYDROCHLOROTHIAZIDE 311 223 11 9
METOPROLOL SUCCINATE 288 248 12 17
ZOLPIDEM TARTRATE 278 198 13 19
LOSARTAN POTASSIUM 273 255 14 29
NEXIUM 273 195 14 14
METOPROLOL TARTRATE 272 221 16 15
POTASSIUM CHLORIDE 252 225 17 11
BUPROPION XL 245 218 18 190
GABAPENTIN 244 199 19 12
BENAZEPRIL HCL 237 186 20 44
CARVEDILOL 232 187 21 22
FLUTICASONE PROPIONATE 216 139 22 39
SERTRALINE HCL 206 179 23 26
LISINOPRIL-HYDROCHLOROTHIAZIDE 203 150 24 21
TAMSULOSIN HCL 201 149 25 32
GLIPIZIDE 195 173 26 62
HYDROCODONE-ACETAMINOPHEN 190 142 S3 27 3
MELOXICAM 183 161 28 18
PROAIR HFA 179 134 29 55
ATENOLOL 179 125 29 23
AMLODIPINE BESYLATE-BENAZEPRIL 167 137 31 41
CLOPIDOGREL 165 140 32 28
LANTUS SOLOSTAR 152 109 33 102
VENLAFAXINE HCL ER 152 129 33 114
TRAZODONE HCL 146 97 35 40
ALENDRONATE SODIUM 142 118 36 38
VERAPAMIL ER 141 121 37 87
GLIMEPIRIDE 131 117 38 27
ROPINIROLE HCL 130 102 39 93
PEN NEEDLE 128 92 40 135
ALLOPURINOL 124 111 41 31
RANITIDINE HCL 120 61 42 49
PANTOPRAZOLE SODIUM 116 94 43 34
SPIRIVA 112 77 44 66
CLONIDINE HCL 108 87 45 35
CRESTOR 107 107 46 25
TRAMADOL HCL 105 92 47 16
WARFARIN SODIUM 104 88 48 24
AMOX TR-POTASSIUM CLAVULANATE 104 75 48 132
ACARBOSE 101 93 50 258
PLAVIX 98 90 51 42
JANUVIA 96 73 52 59
LOSARTAN-HYDROCHLOROTHIAZIDE 96 84 52 57
PAROXETINE HCL 95 61 54 68
FENOFIBRATE 95 74 54 74
FINASTERIDE 95 90 54 108
POLYETHYLENE GLYCOL 3350 91 56 57 67
ADVAIR DISKUS 91 75 57 52
DIGOXIN 90 90 59 65
OXYBUTYNIN CHLORIDE ER 89 64 60 154
PROPRANOLOL HCL 89 79 60 141
DONEPEZIL HCL 89 89 60 30
AMITRIPTYLINE HCL 88 61 R 63 43
MECLIZINE HCL 88 82 63 97
OXYBUTYNIN CHLORIDE 86 60 65 139
NAPROXEN 86 79 65 84
DIOVAN 86 73 65 33
QUINAPRIL HCL 84 52 68 116
BYSTOLIC 84 56 68 86
LIOTHYRONINE SODIUM 84 65 68 312
LIPITOR 82 59 71 77
DILTIAZEM 24HR CD 79 79 72 156
LOVASTATIN 78 78 73 46
AZITHROMYCIN 77 59 74 37
DOXAZOSIN MESYLATE 76 42 75 70
HYDRALAZINE HCL 76 52 75 100
LANSOPRAZOLE 76 39 75 171
METFORMIN HCL ER 74 65 78 54
SYNTHROID 72 62 79 53
METHYLPREDNISOLONE 70 52 80 109
HUMULIN 70-30 69 52 81 241
NAMENDA 68 68 82 36
CYMBALTA 68 39 82 45
ESCITALOPRAM OXALATE 67 23 84 51
LAMOTRIGINE 64 0 85 306
ACTOS 61 54 86 88
PROMETHAZINE HCL 60 31 R 87 104
TRICOR 59 23 88 98
PRIMIDONE 58 45 89 289
VENLAFAXINE HCL 57 26 90 287
TOPIRAMATE 54 30 91 245
TRIAMTERENE-HCTZ 52 47 92 61
DILTIAZEM ER 52 41 92 129
BENAZEPRIL-HYDROCHLOROTHIAZIDE 50 50 94 179
INSULIN SYRINGE 50 49 94 99
JANUMET 50 41 94 194
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.